Investigational Site Number 124008

Newmarket L3Y 8C3

0 studies enrolling now · 3 studies all time

What they study most

Ankylosing Spondylitis, Atherosclerotic Cardiovascular Disease, Rheumatoid Arthritis

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis — Completed
• Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients — Completed